1. Home
  2. SUNS vs ELTX Comparison

SUNS vs ELTX Comparison

Compare SUNS & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.36

Market Cap

129.5M

Sector

Real Estate

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$13.08

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
ELTX
Founded
2023
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.5M
134.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SUNS
ELTX
Price
$9.36
$13.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$12.00
$13.00
AVG Volume (30 Days)
61.4K
135.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
12.70%
N/A
EPS Growth
N/A
38.94
EPS
N/A
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
$165.88
N/A
Revenue Next Year
$46.38
N/A
P/E Ratio
$8.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.80
$4.60
52 Week High
$12.19
$12.62

Technical Indicators

Market Signals
Indicator
SUNS
ELTX
Relative Strength Index (RSI) 50.51 81.85
Support Level $9.31 $7.78
Resistance Level $9.65 N/A
Average True Range (ATR) 0.22 0.95
MACD 0.02 0.43
Stochastic Oscillator 53.52 92.41

Price Performance

Historical Comparison
SUNS
ELTX

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: